Lymphadenectomy issues in endometrial cancer
Yosuke Konno(Hokkaido University of Science), Hidemichi Watari(Hokkaido University of Science), Daisuke Aoki(International University of Health and Welfare), Yasuhisa Terao(Juntendo University), Akira Mitsuhashi(Chiba University), Kimio Ushijima(Kurume University), Hideki Tokunaga(Tohoku University), Michihiro Tanikawa(The University of Tokyo), Ayumi Shikama(University of Tsukuba), Akinori Oki(Ibaraki Prefectural Central Hospital), Toyomi Satoh(University of Tsukuba), Hiroshi Asano(Hokkaido University), Mitsuya Ishikawa(Tokyo National Hospital), Nobuo Yaegashi(Tohoku University), Akira Kikuchi(Niigata Cancer Center Hospital), Koji Horie(Saitama Cancer Center)
Cited by 21
Related Papers
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
|Nature Communications|2019|137
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
|Journal of Translational Medicine|2014|129